CAMP4 Therapeutics Corporation Common Stock
$4.24
$0.21 (+5.21%)
$3.94Day Range$4.27
Key Statistics
Market Cap
$252.90M
Shares Outstanding
62.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 11, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$4.03
Day High
$4.27
Day Low
$3.94
Volume
1.04M
VWAP
$4.23
Prev Close
$4.03
Transactions
--
Acc. Volume
--
About CAMP4 Therapeutics Corporation Common Stock
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
PHARMACEUTICAL PREPARATIONSSIC 283448 employees100 TALCOTT AVENUE, WATERTOWN, MA, 02472617-651-8867IPO Oct 11, 2024US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001736730
- Composite FIGI
- BBG00L2CHQ80
- Share Class FIGI
- BBG00L2CHQ99
- Ticker Root
- CAMP
- SIC Code
- 2834
About CAMP4 Therapeutics Corporation Common Stock (CAMP) Stock
CAMP4 Therapeutics Corporation Common Stock (CAMP) closed the 2026-09-18 session at $4.24, up 5.21% versus the previous close (+0.21). The stock opened at $4.03 and traded between $3.94 and $4.27 during that session. Session trading volume was 1.0M shares. The volume-weighted average price (VWAP) is $4.23.
Camp4 Therapeutics Corp is a clinical-stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. The company focuses on genetic diseases of the central nervous system and liver. Its pipeline products include CMP-CPS-001 and CMP-SYNGAP. The company operates as a single operating segment, R&D, which engages in the development of a new class of RNA-based therapeutics to treat a broad range of genetic diseases.
CAMP4 Therapeutics Corporation Common Stock has a market capitalization of $252.9 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. CAMP is listed on the XNAS exchange. The company employs approximately 48 people. CAMP4 Therapeutics Corporation Common Stock is headquartered in WATERTOWN, MA. The recorded listing date is 2024-10-11.
On this page you can find market CAMP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.